Maria Manuel Donato

Prof. Maria Manuel Donato

Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
PDF file
NAN. Almeida
N. Almeida
JRJ. M. Romãozinho
J. M. Romãozinho
MDMaria Manuel Donato
Maria Manuel Donato
CLC. Luxo
C. Luxo
OCO. Cardoso
O. Cardoso
CSC. Sofia
C. Sofia

1 February 1992 in Systematic and Applied Microbiology
Verified
Journal Article
Closed access
Olga C. NunesOlga C. Nunes
Olga C. Nunes
MDMaria Manuel Donato
Maria Manuel Donato
MCMilton Da Costa
Milton Da Costa

1 August 1990 in Systematic and Applied Microbiology
Verified
Journal Article
Closed access
MDMaria Manuel Donato
Maria Manuel Donato
ESEduardo A. Seleiro
Eduardo A. Seleiro
MCMilton Da Costa
Milton Da Costa

22 March 2014 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
PFPaulo Freire
Paulo Freire
RCRicardo Cardoso
Ricardo Cardoso
PFPedro Figueiredo
Pedro Figueiredo
MDMaria Manuel Donato
Maria Manuel Donato
MFManuela Ferreira
Manuela Ferreira
CSCarlos Sofia
Carlos Sofia

1 November 2014 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PFPaulo Freire
Paulo Freire
PFPedro Figueiredo
Pedro Figueiredo
RCRicardo Cardoso
Ricardo Cardoso
MDMaria Manuel Donato
Maria Manuel Donato
MFManuela Ferreira
Manuela Ferreira
CSCarlos Sofia
Carlos Sofia
Ulcerative colitis (UC) is associated with an increased risk of colorectal cancer. Chromoendoscopy showed superiority to conventional colonoscopy (CC) in surveillance studies including high-risk patients. We aimed to compare chromoendoscopy-guided endomicroscopy (CGE) with CC for intraepithelial neoplasia (IN) detection in patients with longstanding UC without primary sclerosing cholangitis and/or history of IN. One hundred sixty-two patients with longstanding (≥ 8 yr) distal/extensive UC and without primary sclerosing cholangitis and/or history of IN were prospectively randomized to undergo CGE (group A) or CC (group B). Seventeen patients were excluded. In group A (n = 72), circumscribed lesions highlighted by pan-chromoendoscopy were evaluated by endomicroscopy, and targeted biopsy/polypectomy was performed. In group B (n = 73), 4 random biopsies every 10 cm and targeted biopsy/polypectomy of detected lesions were performed. Thirteen IN, all low grade, were detected: 7 IN in group A and 6 in group B (P > 0.05), distributed, respectively, by 6 and 4 patients (P > 0.05). Significantly, more biopsies were performed in group B (4.7 ± 4.9 versus 36.0 ± 6.2, P < 0.001), and the per-biopsy yield of IN was higher in group A (1/48 versus 1/438, P < 0.001). Examination time was 61.5 ± 15.6 minutes in group A and 40.7 ± 8.7 minutes in group B (P < 0.001). The IN detection by endomicroscopy revealed: sensitivity = 85.7%, specificity = 97.9%, positive predictive value = 75.0%, and negative predictive value = 98.9%. CGE does not improve the detection of IN in the endoscopic screening of patients with longstanding UC without primary sclerosing cholangitis and/or history of IN. CGE takes longer than CC, but it decreases the number of biopsies performed and significantly increases the per-biopsy yield of IN. Endomicroscopy is an accurate tool for IN detection.

22 January 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
SPSónia Raquel Pedreiro
Sónia Raquel Pedreiro
AFArtur Figueirinha
Artur Figueirinha
Carlos CavaleiroCarlos Cavaleiro
Carlos Cavaleiro
OCOlga Cardoso
Olga Cardoso
MDMaria Manuel Donato
Maria Manuel Donato
Fernando RamosFernando Ramos
Fernando Ramos
Chritmum maritimum, sea fennel, is a facultative halophyte used in salads, soups, and sauces, as well as used to prepare medicinal juices and aqueous extracts (AE) to treat several ailments. Its essential oil (EO) is used as a spice and aromatizing. In this work, the nutritional (crude protein, fiber, lipids, and ashes content) and HPLC-PDA phenolic profiles were determined. Furthermore, the antioxidant potential of the infusion and of the decoction, as well as the antibacterial activity of both, the AE and EO, were assessed against food-contaminating bacteria. The composition of the EO was also established. Sea fennel exhibited considerable fiber (34.3 ± 1.92%) and mineral content (23.6 ± 4.8%). AE contains chlorogenic acid as the major phenolic compound, 49.7 ± 0.8 mg/g in the infusion dry extract and (26.8 ± 0.9 mg/g in the decoction dry extract). EO contains high amounts of monoterpene hydrocarbons, namely γ-terpinene and sabinene. In regards to the antioxidant activity, IC50 values for the infusion and decoction were, respectively: 36.5 ± 1.4 μg/mL and 44.7 ± 4.4 μg/mL in the DPPH assay; 37.3 ± 2.6 μg/mL and 38.4 ± 1.8 μg/mL, in the ABTS assay. EO is particularly active against Bacillus cereus and Lactobacillus plantarum. The results support the use of sea fennel AE and EO as a potential alternative preservative ingredient for feeds, foods, pharmaceutical, and cosmetic industries, due to the antioxidant activity of infusion and decoction, and antibacterial properties of essential oil.